Gerhard Stadlmayr

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 14, 2022
Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab.

Katharina Stadlbauer, Peter Andorfer, Gerhard Stadlmayr

Pageof 1

Frequent Collaborators

1 joint publications

Katharina Stadlbauer

1 joint publications

Florian Rüker

1 joint publications

Gordana Wozniak-Knopp